Computed from SEC EDGAR filings and closing prices — not copied from any wealth ranking. Dataset . How we calculate this.
Disclosed holdings over time 53 weekly points
What the 1 currently disclosed position would have been worth at each week’s closing price. A rising line means the shares got more valuable, not that this person bought more.
How the line is built
Share counts are as last reported to the SEC and held constant; only prices move.
Insider activity Dec 31, 2024 – Jun 13, 2025
Gabriele M. Cerrone is recorded in filings to the U.S. SEC via EDGAR as member of the board, and reported 10 transactions between Dec 31, 2024 and Jun 13, 2025. The buy and sell totals below count only codes P, S.
Why the other codes are excluded
Share awards (A), shares withheld to pay tax (F), option exercises (M) and gifts (G) also appear in the table, but they are consequences of a pay package or a private transfer, not a decision to buy or sell on the open market. Counting them would turn this into a compensation ranking.
Reported transactions
Price 0.00 is a real reported figure on gifts (G) and share awards (A) — not a missing number. The 19 most recent rows are grouped into 17 lines by date, company and transaction type — open a line to see every lot with its own source link.
How to read this list
Every row is one line of one Form 4 or Form 5, with the filing it came from. Where the record carries no price at all we leave the cell empty instead of guessing one.
The shares and money on a grouped line add up only the lots listed inside that line, and only when every one of them carries the figure. Where a group mixes more than one reporting currency we leave the money blank rather than convert — no source publishes the rate that conversion would need.
-
OKYO Pharma Ltd OKYO A Grant or awardnot a buy/sell decision 22,500 shares $32.6K at $1.45 SEC filing ↗
-
Tiziana Life Sciences Ltd TLSA A Grant or awardnot a buy/sell decision 42,357 shares $41.9K at $0.99 SEC filing ↗
-
OKYO Pharma Ltd OKYO A Grant or awardnot a buy/sell decision 25,000 shares $35.0K at $1.40 SEC filing ↗
-
Tiziana Life Sciences Ltd TLSA A Grant or awardnot a buy/sell decision 15,000 shares $16.7K at $1.11 SEC filing ↗
-
OKYO Pharma Ltd OKYO A Grant or awardnot a buy/sell decision 300,000 shares $516.0K at $1.72 SEC filing ↗
-
Accustem Sciences Inc. ACUT P Open-market purchase × 2 2,400 shares $2.4K
The 2 lots that make up this line, each with the source behind it. Shares Price Value Filing 400 $1.10 $440 SEC filing ↗ 2,000 $1.00 $2.0K SEC filing ↗ -
Accustem Sciences Inc. ACUT P Open-market purchase × 2 52,802 shares $33.6K
The 2 lots that make up this line, each with the source behind it. Shares Price Value Filing 17,802 $0.61 $10.9K SEC filing ↗ 35,000 $0.65 $22.8K SEC filing ↗
Disclosed holdings
Shares is the amount on the form; value is that amount times the closing price shown. Rows with no closing price are left blank, so they may add up to less than the headline figure.
What is not counted here
Each row is one filing you can open. Private companies, real estate, bonds and crypto are not in SEC insider filings and are therefore not counted here.
| Issuer | Ticker | Security | Shares | Close | Value | Form | Reported | Filing |
|---|---|---|---|---|---|---|---|---|
| Accustem Sciences Inc. | ACUT | Common Stock (indirect) | 6,502,400 | $0.16 | $1.0M | 4 | EDGAR ↗ | |
| Tiziana Life Sciences Ltd | TLSA | COMMON STOCK | 44,654,830 | — | — | 3 | EDGAR ↗ | |
| OKYO Pharma Ltd | OKYO | COMMON STOCK | 10,526,416 | — | — | 3 | EDGAR ↗ |
Sources
The filings linked in the tables above are the sources for every figure on this page.
Portrait photograph: Tiziana Life Sciences Ltd (company-published photograph). Original file page on tizianalifesciences.com ↗
Think a number here is wrong? Open the linked filing and compare — how to report it.
Profile record last refreshed Sep 8, 2026.